Professional bodies publish joint statement on achieving success with the women’s health hub model
The women’s health hub model represents a significant opportunity to improve access, experiences and outcomes in women’s healthcare.
The women’s health hub model represents a significant opportunity to improve access, experiences and outcomes in women’s healthcare.
A clinical psychology masters student at Newcastle University is conducting a research project on the topic of physical activity in females experiencing menopausal symptoms.The main purpose of this study [...]
The Lifespan Lab based at the University of Nottingham would like to invite women who have experienced periods to participate in their research.
A new study has been launched investigating emotional processing in premenstrual syndrome to better understand the role that psychological factors play in premenstrual distress.
Over 37,700 certificates have already been purchased following the launch of the Hormone Replacement Therapy (HRT) prescription pre-payment certificate (PPC) As a result, over £1.13 million has been saved [...]
Joint safety alert from the British Menopause Society, Faculty of Sexual & Reproductive Healthcare, Royal College of General Practitioners, Royal College of Obstetricians & Gynaecologists, Society for Endocrinology and [...]
From today (1 April) women in England will be able to access cheaper Hormone Replacement Therapy (HRT) to help with menopause symptoms New HRT prescription prepayment certificate (PPC) will [...]
Researchers at the University of Birmingham and University of Exeter would like to know more about your experiences. We are interested in exploring how feelings associated with shame can [...]
The National Institute of Health Research is looking to fund research on the benefits and risks of testosterone in women during the menopause. A team of clinicians, researchers, and [...]
The current controversy surrounding testosterone treatment is causing confusion amongst women and healthcare professionals alike. British Menopause Society guidance follows NICE NG23 which recommends that testosterone is used for low libido after other options have been exhausted.